• 
  Delphine Fessart, Ines Villamor, Eric Chevet, Frederic Delom, Jacques Robert. Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer. Open Biology, 2022, 12 (7), pp.220068. ⟨10.1098/rsob.220068⟩. ⟨hal-03777236⟩
• 
  Gayathri Sundaram, Alban Bessede, David Gilot, Ananda Staats Pires, Larry S. Sherman, et al.. Prophylactic and Therapeutic Effect of Kynurenine for Experimental Autoimmune Encephalomyelitis (EAE) Disease. International Journal of Tryptophan Research, 2022, 15, ⟨10.1177/11786469221118657⟩. ⟨hal-03775399⟩
• 
  El-Mahdi Hafiani, Pierre Cassier, Serge Aho, Pierre Albaladejo, Hélène Beloeil, et al.. Guidelines for clothing in the operating theatre, 2021. Anaesthesia Critical Care & Pain Medicine, 2022, 41 (3), pp.101084. ⟨10.1016/j.accpm.2022.101084⟩. ⟨hal-03690335⟩
• 
  Julien Corné, Véronique Quillien, Céline Callens, Pascal Portois, François-Clément Bidard, et al.. Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients. Clinica Chimica Acta, 2023, 545, pp.117366. ⟨10.1016/j.cca.2023.117366⟩. ⟨hal-04089182⟩
• 
  Stephen B Beres, Randall J Olsen, S Wesley Long, Jesus M Eraso, Sarrah Boukthir, et al.. Analysis of the Genomics and Mouse Virulence of an Emergent Clone of Streptococcus dysgalactiae Subspecies equisimilis. Microbiology Spectrum, 2023, pp.e0455022. ⟨10.1128/spectrum.04550-22⟩. ⟨hal-04061267⟩
• 
  Cyrille Féray, Loic Campion, Philippe Mathurin, Isabelle Archambreaud, Xavier Mirabel, et al.. TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial. JHEP Reports Innovation in Hepatology, 2023, 5 (4), pp.100689. ⟨10.1016/j.jhepr.2023.100689⟩. ⟨hal-04044132⟩
• 
  S. Mesbah, H. Mesbah, L.-A. Haumont, Ronan Thibault. The evaluation of consumed food portions as a screening test for malnutrition in the older people living in a nursing home: A cross-sectional pilot study. Nutrition Clinique et Métabolisme, 2023, 37 (1), pp.62-67. ⟨10.1016/j.nupar.2022.12.006⟩. ⟨hal-04019404⟩
• 
  L. Heliez, C Ricordel, P. Bécuwe, R Pedeux. Newly identified tumor suppressor functions of ING proteins. Current Opinion in Pharmacology, 2023, 68, pp.102324. ⟨10.1016/j.coph.2022.102324⟩. ⟨hal-03931315⟩
• 
  Pierre Mordant, Solenn Brosseau, Bernard Milleron, Nicola Santelmo, Séverine Fraboulet-Moreau, et al.. Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study. Clinical Lung Cancer, 2023, 24 (1), pp.1-10. ⟨10.1016/j.cllc.2022.08.013⟩. ⟨hal-03800571⟩
• 
  Rémy Pedeux. Dommages à l’ADN et ondes millimétriques : Analyse de la voie de réponse aux dommages à l’ADN en réponse à une co-exposition comprenant les ondes millimétriques. Les cahiers de la Recherche. Santé, Environnement, Travail, 2022, pp.37-39. ⟨anses-04109441⟩
• 
  Alice Coquet, Audrey Sion, Antoine Bourgoin, Mickael Ropars, Hélène Beloeil. Transversus Abdominis Plane Block for Anterior Lumbar Interbody Fusion: a randomized controlled trial. Spine Journal, 2023, ⟨10.1016/j.spinee.2023.03.013⟩. ⟨hal-04088362⟩
• 
  Florence Poizeau, Frederic Balusson, Florian Lemaitre, Camille Tron, Marc Pracht, et al.. The concomitant use of proton pump inhibitors and BRAF/MEK inhibitors in metastatic melanoma. British Journal of Dermatology, 2023, 188 (4), pp.482-490. ⟨10.1093/bjd/ljac085⟩. ⟨hal-04013531⟩
• 
  Julien Edeline, Jean-Frédéric Blanc. Difficulties for providing evidence in hepatocellular carcinoma with Child-Pugh B liver function. Liver International, 2023, 43 (2), pp.274-275. ⟨10.1111/liv.15495⟩. ⟨hal-03972207⟩
• 
  Sonia Guerin, Krystel Nyangoh Timoh, Zine-Eddine Khene, Chloé Rousseau, Yann Pierre Codet, et al.. Outpatient laparoscopic sacrocolpopexy: Feasibility and patient satisfaction. Journal of Gynecology Obstetrics and Human Reproduction, 2021, 50 (7), pp.102118. ⟨10.1016/j.jogoh.2021.102118⟩. ⟨hal-03421605⟩
• 
  Marie Métairie, Louise Benoit, Meriem Koual, Enrica Bentivegna, Henri Wohrer, et al.. A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer. Cancers, 2023, 15 (3), pp.706. ⟨10.3390/cancers15030706⟩. ⟨hal-04069350⟩
• 
  Charles Ricordel, L Chaillot, E. -I. Vlachavas, M Logotheti, A Jouannic, et al.. Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer. Scientific Reports, 2023, 13 (1), pp.3626. ⟨10.1038/s41598-023-30536-9⟩. ⟨hal-04062199⟩
• 
  Marie Pécout, Jérôme Phalippou, Henri Azaïs, Lobna Ouldamer, Pierre Adrien Bolze, et al.. Comparison of retroperitoneal and transperitoneal surgical routes in laparoscopic nodal staging for locally advanced cervical cancers (FIGO IB3-IVA). EJSO - European Journal of Surgical Oncology, 2022, 48 (9), pp.2061-2067. ⟨10.1016/j.ejso.2022.05.005⟩. ⟨hal-03690683⟩
• 
  Véronique Vendrely, Claire Lemanski, Pascal Pommier, Karine Le Malicot, Angélique Saint, et al.. Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE. Radiotherapy & Oncology, 2023, 183, pp.109542. ⟨10.1016/j.radonc.2023.109542⟩. ⟨hal-04016479⟩
• 
  Luciana L. Almada, Kim Barroso, Sandhya Sen, Murat Törüner, Ashley N Sigafoos, et al.. GLI1, a novel target of the ER stress regulator p97/VCP, promotes ATF6f-mediated activation of XBP1. Biochimica et Biophysica Acta - Gene Regulatory Mechanisms , 2023, 1866, pp.194924. ⟨10.1016/j.bbagrm.2023.194924⟩. ⟨hal-04016307⟩
• 
  Olivier Bylicki, Pascale Tomasini, Gervais Radj, Florian Guisier, Isabelle Monnet, et al.. Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018. European Journal of Cancer, 2023, 183, pp.38-48. ⟨10.1016/j.ejca.2023.01.014⟩. ⟨hal-04016683⟩

490

582